Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2025-04-25 00:00:00 ET · period of report 2024-07-10 · accession 0001104659-25-039417 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-04-25 | 2024-07-10+ | ARMP | Birx Deborah | CEO, Dir | F - Tax | $2.53 | -29.0K | 231.0K | -11% | -$73.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-10 | F | D | 22,925 | $2.68 | 237,075 | D | — | — | (F1) Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units. |
| 2 | Common | Common Stock | 2025-03-14 | F | D | 6,061 | $1.95 | 231,014 | D | — | — | (F1) Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units. |